journal article·2026-02

Active Transport of Biomimetic Cascaded Nanozymes Across Blood–Brain Barrier to Scavenge ROS and Alleviate Neuroinflammation Against Cerebral Ischemia Reperfusion Injury

Yuqi Wu, Jie Xu, Xinxin Wang, Han Li, Fan Wu, Jian Ruan, Dong Chen, Jianpeng Sheng, Dingcheng Zhu, Junqiu Liu, Baiheng Wu

Advanced Functional Materials· Volume 36· Issue 17
Publisher page

Abstract

Abstract The rational design of potent antioxidative agents with active transport across blood–brain barrier (BBB) is critically required for mitigating ischemic reperfusion‐induced reactive oxygen species (ROS)‐mediated neuroinflammation and neural injury in ischemic stroke therapy. Herein, a biomimetic nanozyme is engineered by integrating copper and selenium, key catalytic sites of natural antioxidant superoxide dismutase and glutathione peroxidase, into mesoporous polydopamine scaffolds (mPDA‐Cu/Se), yielding cascaded enzymatic activities for robust ROS scavenging. This nanozyme is further functionalized with a BBB‐penetrating peptide RVG29 and biocompatible red blood cell membrane (T‐mPDA‐Cu/Se) for enhanced BBB penetration and ischemic neuronal tissues accumulation in a transient middle cerebral artery occlusion rat model, where it effectively mitigates oxidative damage and neuron apoptosis. T‐mPDA‐Cu/Se also mitigates neuroinflammation‐induced injury by inhibiting astrocyte activation, microglia pro‐inflammatory polarization, and proinflammatory cytokines secretion, thus achieving reduced infarct volume and improved neuronal recovery without noticeable systemic toxicity. Collectively, this study provides a promising neuroprotective approach against reperfusion‐induced neuron injury in ischemic stroke.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Organosilicon Chemistry and Material Technology Ministry of Education Zhejiang Key Laboratory of Organosilicon Material Technology College of Material, Chemistry and Chemical Engineering Hangzhou Normal University Hangzhou Zhejiang 311121 P. R. China

Department of Medical Oncology The First Affiliated Hospital School of Medicine Zhejiang University Hangzhou Zhejiang 310003 P. R. China

Department of Neurosurgery The First Affiliated Hospital School of Medicine Zhejiang University Hangzhou Zhejiang 310003 P. R. China

Chinese Institutes for Medical Research Capital Medical University Beijing 100020 P. R. China

Funding

National Natural Science Foundation of China

References (52)

Show source-provided references
1. 10.1212/WNL.000000000001278110.1212/WNL.0000000000012781 ↗
2. 10.1186/s12916-019-1397-310.1186/s12916-019-1397-3 ↗
3. 10.1016/S1474-4422(23)00277-610.1016/S1474-4422(23)00277-6 ↗
4. 10.1001/jama.2018.849610.1001/jama.2018.8496 ↗
5. 10.1016/S1474-4422(22)00519-110.1016/S1474-4422(22)00519-1 ↗
6. 10.1038/s41392-022-01064-110.1038/s41392-022-01064-1 ↗
7. 10.1038/s41586-020-2551-y10.1038/s41586-020-2551-y ↗
8. 10.1007/s42765-022-00153-810.1007/s42765-022-00153-8 ↗
9. 10.1016/j.actbio.2022.05.02110.1016/j.actbio.2022.05.021 ↗
10. 10.1002/ange.20180230910.1002/ange.201802309 ↗
11. 10.1016/j.neurobiolaging.2016.07.02910.1016/j.neurobiolaging.2016.07.029 ↗
12. 10.1038/nrneurol.2015.14410.1038/nrneurol.2015.144 ↗
13. 10.1038/s41577-019-0197-510.1038/s41577-019-0197-5 ↗
14. 10.1161/STROKEAHA.118.02381510.1161/STROKEAHA.118.023815 ↗
15. 10.1016/j.clineuro.2022.10729910.1016/j.clineuro.2022.107299 ↗
16. 10.1021/acsnano.8b0199410.1021/acsnano.8b01994 ↗
17. 10.1002/adfm.20220402510.1002/adfm.202204025 ↗
18. 10.1002/adfm.20231527510.1002/adfm.202315275 ↗
19. 10.1038/s41467-023-43070-z10.1038/s41467-023-43070-z ↗
20. 10.1002/adma.20221014410.1002/adma.202210144 ↗
21. 10.1002/adma.20250357610.1002/adma.202503576 ↗
22. 10.1002/EXP.2022004110.1002/EXP.20220041 ↗
23. 10.1126/sciadv.abb269510.1126/sciadv.abb2695 ↗
24. 10.1038/s41573-021-00139-y10.1038/s41573-021-00139-y ↗
25. 10.1002/smll.20241040410.1002/smll.202410404 ↗
26. 10.1126/sciadv.aay975110.1126/sciadv.aay9751 ↗
27. 10.1002/adma.20240952910.1002/adma.202409529 ↗
28. 10.1021/jacs.6b1101310.1021/jacs.6b11013 ↗
29. 10.1021/acsnano.3c0176010.1021/acsnano.3c01760 ↗
30. 10.1016/j.jconrel.2017.08.02710.1016/j.jconrel.2017.08.027 ↗
31. 10.1002/adma.20180371710.1002/adma.201803717 ↗
32. 10.1038/s41596-022-00784-610.1038/s41596-022-00784-6 ↗
33. 10.1021/jacs.9b0209110.1021/jacs.9b02091 ↗
34. 10.1016/j.apsusc.2022.15595010.1016/j.apsusc.2022.155950 ↗
35. 10.1038/306284a010.1038/306284a0 ↗
36. 10.1038/s41467-025-62986-210.1038/s41467-025-62986-2 ↗
37. 10.1016/j.biomaterials.2009.02.05110.1016/j.biomaterials.2009.02.051 ↗
38. Wang R. · Int. J. Nanomed. · 2012 · 7 · 4185
39. 10.1002/med.2181710.1002/med.21817 ↗
40. 10.1007/s12264-022-00859-010.1007/s12264-022-00859-0 ↗
41. 10.1016/j.jconrel.2024.02.03910.1016/j.jconrel.2024.02.039 ↗
42. 10.1039/D0AN02164D10.1039/D0AN02164D ↗
43. 10.15541/jim2022071610.15541/jim20220716 ↗
44. 10.3389/fneur.2019.0128910.3389/fneur.2019.01289 ↗
45. 10.1038/s41419-018-0450-z10.1038/s41419-018-0450-z ↗
46. 10.1016/S0076-6879(99)01078-210.1016/S0076-6879(99)01078-2 ↗
47. 10.1016/j.coph.2017.07.01410.1016/j.coph.2017.07.014 ↗
48. 10.1161/01.STR.20.1.8410.1161/01.STR.20.1.84 ↗
49. 10.1016/S0028-3908(00)00005-810.1016/S0028-3908(00)00005-8 ↗
50. 10.3389/fneur.2021.66751110.3389/fneur.2021.667511 ↗
51. 10.1038/s41598-024-76414-w10.1038/s41598-024-76414-w ↗
52. 10.4110/in.2012.12.2.4110.4110/in.2012.12.2.41 ↗